PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

76 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Moser, R.* et al.: A survey of cancer patients' interest in undertaking exercise to promote relaxation during radiotherapy for breast cancer and metastatic cancer. Radiat. Oncol. 19:68 (2024)
2.
Schwab, M.* et al.: The radiation- and chemo-sensitizing capacity of diclofenac can be predicted by a decreased lactate metabolism and stress response. Radiat. Oncol. 19:7 (2024)
3.
Dapper, H.* et al.: Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent. Radiat. Oncol. 18:44 (2023)
4.
Schnöller, L.E.* et al.: Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data. Radiat. Oncol. 18:51 (2023)
5.
Borm, K.J.* et al.: Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer. Radiat. Oncol. 17:27 (2022)
6.
Schnöller, L.E.* et al.: Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy. Radiat. Oncol. 17:79 (2022)
7.
Corradini, S.* et al.: X-change symposium: Status and future of modern radiation oncology-from technology to biology. Radiat. Oncol. 16:27 (2021)
8.
Mei, J.* et al.: Development of a model for fibroblast-led collective migration from breast cancer cell spheroids to study radiation effects on invasiveness. Radiat. Oncol. 16:159 (2021)
10.
Vogel, M.M. et al.: A survey among German-speaking radiation oncologists on PET-based radiotherapy of prostate cancer. Radiat. Oncol. 16:82 (2021)
11.
Brix, N.* et al.: The clonogenic assay: Robustness of plating efficiency-based analysis is strongly compromised by cellular cooperation. Radiat. Oncol. 15:248 (2020)
12.
Combs, S.E. et al.: First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments. Radiat. Oncol. 15:74 (2020)
13.
Gaasch, A.* et al.: Heart sparing radiotherapy in breast cancer: The importance of baseline cardiac risks. Radiat. Oncol. 15:117 (2020)
14.
Käsmann, L.* et al.: Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review. Radiat. Oncol. 15:214 (2020)
15.
Pigorsch, S.U.* et al.: Report on planning comparison of VMAT, IMRT and helical tomotherapy for the ESCALOX-trial pre-study. Radiat. Oncol. 15:253 (2020)
16.
Samaga, D. et al.: Single-center versus multi-center data sets for molecular prognostic modeling: A simulation study. Radiat. Oncol. 15:109 (2020)
17.
Scharl, S.* et al.: Is local radiotherapy a viable option for patients with an opening of the ventricles during surgical resection of brain metastases? Radiat. Oncol. 15:276 (2020)
18.
Schaule, J.* et al.: Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8). Radiat. Oncol. 15:280 (2020)
19.
Schaule, J.* et al.: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy Melanoma brain metastases prognostic score. Radiat. Oncol. 15:135 (2020)
20.
Schüttrumpf, L. et al.: Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck-results from an unselected cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer". Radiat. Oncol. 15:7 (2020)